Follow
Miguel Madrid-Mencía
Miguel Madrid-Mencía
Emerging Solutions - Illumina
Verified email at illumina.com - Homepage
Title
Cited by
Cited by
Year
STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells
L Richart, E Lapi, V Pancaldi, M Cuenca-Ardura, ECS Pau, ...
Nucleic Acids Research 49 (19), 11005-11021, 2021
182021
Using GARDEN-NET and ChAseR to explore human haematopoietic 3D chromatin interaction networks
M Madrid-Mencía, E Raineri, TBN Cao, V Pancaldi
Nucleic Acids Research 48 (8), 4066-4080, 2020
172020
Single-cell virtual cytometer allows user-friendly and versatile analysis and visualization of multimodal single cell RNAseq datasets
F Pont, M Tosolini, Q Gao, M Perrier, M Madrid-Mencía, TS Huang, ...
NAR genomics and bioinformatics 2 (2), lqaa025, 2020
152020
Insights on TAM formation from a Boolean model of macrophage polarization based on in vitro studies
M Marku, N Verstraete, F Raynal, M Madrid-Mencía, M Domagala, ...
Cancers 12 (12), 3664, 2020
122020
Low replicative stress triggers cell-type specific inheritable advanced replication timing
L Courtot, E Bournique, C Maric, L Guitton-Sert, M Madrid-Mencía, ...
International Journal of Molecular Sciences 22 (9), 4959, 2021
7*2021
DoriTool: a bioinformatics integrative tool for post-association functional annotation
I Martín-Antoniano, L Alonso, M Madrid, E Lopez de Maturana, N Malats
Public Health Genomics 20 (2), 126-135, 2017
62017
Cytidine deaminase protects pancreatic cancer cells from replicative stress and drives resistance to DNA-targeting drugs
A Lumeau, N Bery, A Francès, M Gayral, C Ribeyre, C Lopez, A Névot, ...
bioRxiv, 2021.10. 23.465566, 2021
22021
Cytidine deaminase resolves replicative stress and protects pancreatic cancer from DNA-targeting drugs
A Lumeau, N Bery, A Frances, M Gayral, G Labrousse, C Ribeyre, ...
Cancer Research 84 (7), 1013-1028, 2024
2024
Abstract PO-043: Cytidine deaminase protects pancreatic cancer cells from replicative stress and drive response to DNA-targeting drugs
A Lumeau, N Bery, C Ribeyre, S Elkaoutari, G Labrousse, ...
Cancer Research 81 (22_Supplement), PO-043-PO-043, 2021
2021
Cytidine deaminase protects pancreatic cancer cells from replicative stress and drive response to DNA-targeting drugs.
A Lumeau, N Bery, C Ribeyre, S Elkaoutari, G Labrousse, ...
CANCER RESEARCH 81 (22), 29-30, 2021
2021
GEM-DeCan: Improved tumor immune microenvironment profiling through novel gene expression and DNA methylation signatures predicts immunotherapy response
T Xie, J Pernet, N Verstraete, M Madrid-Mencía, MS Kuo, A Hucteau, ...
2021
GEM-DeCan: Improving tumor immune microenvironment profiling by the integration of novel gene expression and DNA methylation deconvolution signatures
T Xie, J Pernet, N Verstraete, M Madrid-Mencía, MS Kuo, A Hucteau, ...
bioRxiv, 2021.04. 09.439207, 2021
2021
A new role for cytidine deaminase in the control of DNA replication and genomic stability
A Lumeau, A Frances, M Madrid-Mencia, C Ribeyre, M Pillaire, ...
Pancreatology 20, S41-S42, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–13